Latest Morocco News

Rubicon Water has told ASX that the selection of a joint venture bid containing about A$12 million of its technology was price-sensitive information. The company said it only learned of the decision when it appeared on Morocco’s procurement portal, then lodged its announcement after an overnight review and a four-second technical delay.

Rubicon Water’s technology has been selected as part of a joint venture bid for a major Moroccan irrigation upgrade covering 69,600 hectares. The opportunity could become its largest EMEA contract, but formal execution remains subject to a 15-day appeal period and subsequent commissioning.

Zeus Resources has reported high-grade surface antimony results in Morocco while moving to acquire a copper-gold project in Mauritania. The exploration story is advancing, but the audited accounts flag a material uncertainty over the company’s ability to continue as a going concern.

Frontier Digital Ventures has shrunk its top line by 27% as it exits low-margin businesses, but the reset delivered higher EBITDA, a 17% margin and near-total free cash flow conversion in the first half of FY2026. The next test is whether pricing and cost discipline can lift earnings without further customer erosion.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

Beonic Ltd has fully subscribed the shortfall placement from its recent pro-rata entitlement offer, with nearly 18 million shares set for issuance early next month.

Recce Pharmaceuticals has signed a non-binding term sheet with a major Middle Eastern pharma player for exclusive rights to commercialise its R327 Topical Gel across the MENA region, targeting a high diabetes burden market.

Canadian Phosphate (ASX: CP8) has locked in a five-year exploration permit for its Wapiti Phosphate Project in British Columbia, setting the stage for immediate drilling and a refreshed JORC resource estimate by late 2026.

BlinkLab has completed onboarding all clinical sites for its pivotal FDA autism trial, enrolled the first participant, and launched a nationwide autism screening program in Morocco. A recent A$17.7 million capital raise will fund further trials and expansion into ADHD diagnostics.

Canadian Phosphate is accelerating its mine-to-market phosphate strategy in North America, driven by geopolitical tensions that spotlight vulnerabilities in global fertilizer supply chains. The company progresses drilling preparations, bulk sampling, and feasibility studies for a Single Super Phosphate plant while maintaining a solid cash position.

Frontier Digital Ventures reported a sharp 18% revenue decline in FY2025 due to shedding low-margin businesses, yet achieved a remarkable 205% jump in EBITDA, signalling a successful pivot to core classifieds in emerging markets.

Ava Risk Group secures key government contracts and expands its technology trials in Australia, the US, and the Middle East during Q3 FY2026, reinforcing its position in critical infrastructure security.